低分子肝素治疗高原心脏病伴高原红细胞增多症56例  

Effects of Framin on 56 Cases of High Altitude Cardiopathy Merged High Altitude Polycythemia

作　　者：侯同川[1] 余军[1] 刘玉江[1] 程波[1] 普布扎西[1] 

机构地区：[1]解放军第41医院内科,西藏山南856000

出　　处：《临床军医杂志》2003年第4期15-16,共2页Clinical Journal of Medical Officers

摘　　要：目的 观察低分子肝素对高原心脏病伴高原红细胞增多症(HAPC)血流动力学的影响及疗效。方法 将56例高原心脏病伴HAPC患者随机分为治疗组和对照组,分别进行常规治疗和加用低分子肝素治疗。结果 低分子肝素组治疗前后,血液流变指标明显改善,全血粘度、血浆粘度、纤维蛋白原、血沉均明显下降(P<0.01),心功能明显改善。结论 低分子肝素能明显改善高原心脏病伴HAPC血流动力学状态,并且能明显改善心功能。Objective To investigate the effect of Framin on hemorhcology in treatment of High Altitude Cardiopathy merged High Altitude Polycythemia. Methods In the present experiment,56 patients were randomly divided into conventionality treated group and Figmin treated group ( used Framin base on conventionality treated group). Results Hemorheology significantly improved in cases before and after treatment. ( P < 0.01 ) function of heart evidently imcreased. Conclusion The study indicated that Frgmin can improve state of Hemorhcology in cases with High Altitude Cardiopathy merged High Altitude Polycythemia ,and ovidently imcreased function of heart.

关 键 词：高原心脏病 高原红细胞增多症 低分子肝素 血流动力学 药物治疗 

分 类 号：R541[医药卫生—心血管疾病] R555.1[医药卫生—内科学]